| James D Salisbury, DO | |
|
2700 Wayne Memorial Dr, Goldsboro, NC 27534-9494 | |
| (919) 731-6060 | |
| Not Available |
| Full Name | James D Salisbury |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 7 Years |
| Location | 2700 Wayne Memorial Dr, Goldsboro, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285155283 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 5101023505 (Michigan) | Secondary |
| 207P00000X | Emergency Medicine | 2021-00694 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wayne Memorial Hospital | Goldsboro, NC | Hospital |
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Goldsboro Emergency Medical Specialists Inc | 5294633293 | 12 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announces its new Healthland Analytics solution. Developed in partnership with Performance Management Institute (PMI), Healthland Analytics extracts relevant data from the Healthland Financial System solutions and other sources and presents it in easy-to-grasp, actionable snapshots of financial, operational and clinical performance.
Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.
The presence of greenspaces near homes and schools is strongly associated with improved physical activity and mental health outcomes in kids, according to a massive review of data from nearly 300 studies.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.
› Verified 8 days ago
| Entity Name | Goldsboro Emergency Medical Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164418232 PECOS PAC ID: 5294633293 Enrollment ID: O20031229000879 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announces its new Healthland Analytics solution. Developed in partnership with Performance Management Institute (PMI), Healthland Analytics extracts relevant data from the Healthland Financial System solutions and other sources and presents it in easy-to-grasp, actionable snapshots of financial, operational and clinical performance.
Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.
The presence of greenspaces near homes and schools is strongly associated with improved physical activity and mental health outcomes in kids, according to a massive review of data from nearly 300 studies.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.
› Verified 8 days ago
| Entity Name | Ecep Ii Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255407680 PECOS PAC ID: 5092709931 Enrollment ID: O20040413000773 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announces its new Healthland Analytics solution. Developed in partnership with Performance Management Institute (PMI), Healthland Analytics extracts relevant data from the Healthland Financial System solutions and other sources and presents it in easy-to-grasp, actionable snapshots of financial, operational and clinical performance.
Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.
The presence of greenspaces near homes and schools is strongly associated with improved physical activity and mental health outcomes in kids, according to a massive review of data from nearly 300 studies.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James D Salisbury, DO Po Box K, Goldsboro, NC 27533-9710 Ph: (919) 580-0008 | James D Salisbury, DO 2700 Wayne Memorial Dr, Goldsboro, NC 27534-9494 Ph: (919) 731-6060 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announces its new Healthland Analytics solution. Developed in partnership with Performance Management Institute (PMI), Healthland Analytics extracts relevant data from the Healthland Financial System solutions and other sources and presents it in easy-to-grasp, actionable snapshots of financial, operational and clinical performance.
Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.
The presence of greenspaces near homes and schools is strongly associated with improved physical activity and mental health outcomes in kids, according to a massive review of data from nearly 300 studies.
A first-time finding of intraocular pressure increases in patients with no personal or family history of glaucoma following anti-VEGF treatment for wet age-related macular degeneration (AMD), and a report on a simple, low-cost method that could revolutionize vision screening and treatment in developing countries, are highlights of today's Scientific Program of the 2009 Joint Meeting of the American Academy of Ophthalmology (AAO) and the Pan-American Association of Ophthalmology (PAAO).
Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has granted full approval of SYNRIBO (omacetaxine mepesuccinate) for injection. This oncology portfolio product received an accelerated approval in October, 2012 with additional clinical trial data required to fulfill post marketing requirements set forth by the FDA.
› Verified 8 days ago
Dr. Craig Alan Soltis, M. D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 | |
Dr. Daniel Lowell Drotts, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Emergency Dept, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-731-6534 | |
Dr. Frederick L Potts, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Wayne Memorial Dr, Emergency Dept, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 | |
Dr. Israel Landa, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Drive, Emergency Department, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-731-6534 | |
Dr. Lloyd Hamlin Smith, M. D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 | |
Sidney B Mccall, PARAMEDIC Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 817 N Spence Ave, Goldsboro, NC 27534 Phone: 919-687-6004 |